JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 131 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | 0.0% | 562 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 562 | -14.8% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 660 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 660 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 660 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 660 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -42.9% | 660 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 660 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -44.4% | 660 | -43.1% | 0.00% | – |
| Q3 2020 | $9,000 | +200.0% | 1,160 | +132.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|